These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 3313682)

  • 21. Antinuclear autoantibodies in chronic liver diseases.
    Konikoff F; Isenberg DA; Barrison I; Theodor E; Shoenfeld Y
    Hepatogastroenterology; 1989 Oct; 36(5):341-5. PubMed ID: 2620901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH.
    Frazer IH; Kronborg IJ; Mackay IR
    Clin Exp Immunol; 1983 Oct; 54(1):213-8. PubMed ID: 6616969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
    Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
    Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to ribosomes in chronic active hepatitis.
    Gerber MA; Shapiro JM; Smith H; Lebwohl O; Schaffner F
    Gastroenterology; 1979 Jan; 76(1):139-43. PubMed ID: 758135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients.
    Lohse AW; Gerken G; Mohr H; Löhr HF; Treichel U; Dienes HP; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1995 Sep; 33(9):527-33. PubMed ID: 8525656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the immune response play a role in the pathogenesis of chronic liver disease?
    Mondelli MU; Manns M; Ferrari C
    Arch Pathol Lab Med; 1988 May; 112(5):489-97. PubMed ID: 3282484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
    Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
    Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
    Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y; Tang Q; Zhu W; Zhang X; You L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of chronic liver diseases with the presence of serum markers of the hepatitis B virus].
    Aprosina ZG; Lopatkina TN; Iakovenko EP; Krel' PE; Saiapina ES
    Ter Arkh; 1988; 60(11):23-8. PubMed ID: 3238571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical correlation of antimitochondrial antibodies.
    Zuber MA; Recktenwald C
    Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection and significance of HBsAg associated receptors for polymerized human serum albumin in acute hepatitis B virus infection].
    Gerken G; Manns M; Hess G; Slusarczyk J; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1986 Feb; 24(2):93-9. PubMed ID: 3008456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.
    de Moura MC; Vernace SJ; Paronetto F
    Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.
    Frazer IH; Mackay IR
    Clin Exp Immunol; 1984 Aug; 57(2):429-37. PubMed ID: 6432384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of the hepatitis Delta virus and its incidence in virus B positive chronic liver diseases].
    Horváth G; Tolvaj G; Dávid K
    Orv Hetil; 1992 Jul; 133 Suppl 1():39-44. PubMed ID: 1630804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.
    Bernstein RM; Neuberger JM; Bunn CC; Callender ME; Hughes GR; Williams R
    Clin Exp Immunol; 1984 Mar; 55(3):553-60. PubMed ID: 6368058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.